Minoxidil Market, by Type (5% Minoxidil and 2% Minoxidil), by Route of Administration (Oral and Topical), by Gender (Male and Female), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, L

Minoxidil Market, by Type (5% Minoxidil and 2% Minoxidil), by Route of Administration (Oral and Topical), by Gender (Male and Female), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Minoxidil is an antihypertensive available in topical as well as oral solution used for hair loss treatment. It helps to stimulate hair growth and to slow balding. This drug is U.S. Food & Drug Administration (U.S. FDA) approved for androgenetic alopecia and female pattern hair loss. Moreover, it is also available off label for alopecia areata, beard enhancement, and central centrifugal cicatricial alopecia.
Market Dynamics
Rising incidence of androgenetic alopecia is expected to drive the global minoxidil market growth. According to the National Library of Medicine (NLM), a medical library which is part of the National Institutes of Health (NIH), androgenetic alopecia affects approximately 50 million men and 30 million women in the U.S.
However, side effects of minoxidil is expected to hinder the market growth. For instance, according to the National Center for Biotechnology Information (NCBI), August 2021, topical minoxidil show some side effects such as irritant contact dermatitis with the typical symptoms of itching and scaling.
Key features of the study:
This report provides in-depth analysis of the global minoxidil market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global minoxidil market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Pfizer Inc., ATOM PHARMA, LGM Pharma, Perrigo Company plc, AmWiner & Raphe Holdings, Johnson and Johnson Services, Inc., Sigma Aldrich (Merck KGaA), Actavis Pharma, Inc., Remedy Repack, Apotex Corporation, TRILOGIC LTD, DS LABORATORIES, INC., Incredible Products, S.A. de C.V., and Taisho Pharmaceutical Co., Ltd among others
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global minoxidil market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global minoxidil market
Detailed Segmentation:
Global Minoxidil Market, By Type:
5% Minoxidil
2% Minoxidil
Global Minoxidil Market, By Route of Administration:
Oral
Topical
Global Minoxidil Market, By Gender:
Male
Female
Global Minoxidil Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Minoxidil Market, By Region:
North America
By Type:
5% Minoxidil
2% Minoxidil
By Route of Administration:
Oral
Topical
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
U.S.
Canada
Latin America
By Type:
5% Minoxidil
2% Minoxidil
By Route of Administration:
Oral
Topical
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Type:
5% Minoxidil
2% Minoxidil
By Route of Administration:
Oral
Topical
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Type:
5% Minoxidil
2% Minoxidil
By Route of Administration:
Oral
Topical
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Type:
5% Minoxidil
2% Minoxidil
By Route of Administration:
Oral
Topical
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country:
GCC
Israel
Rest of Middle East
Africa
By Type:
5% Minoxidil
2% Minoxidil
By Route of Administration:
Oral
Topical
By Gender:
Male
Female
By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Pfizer Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
ATOM PHARMA
LGM Pharma
Perrigo Company plc
AmWiner & Raphe Holdings
Johnson and Johnson Services, Inc.
Sigma Aldrich (Merck KGaA)
Actavis Pharma, Inc.
Remedy Repack
Apotex Corporation
TRILOGIC LTD
DS LABORATORIES, INC.
Incredible Products, S.A. de C.V.
Taisho Pharmaceutical Co., Ltd
“*” marked represents similar segmentation in other categories in the respective section.